Skip to main content
Clinical Trials/JPRN-jRCT1032200110
JPRN-jRCT1032200110RecruitingPhase 2

Safety and efficacy of endoscopic ultrasonography-guided balloon-occluded sclerotherapy

Kato Naoya0 sites6 target enrollmentStarted: September 9, 2020Last updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Kato Naoya
Enrollment
6

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • 1) Patients with esophageal varices
  • 2) Child-Pugh score A or B
  • 3) Age 20 years or older (any gender)
  • 4) Patients who have been fully informed about the study and have given their voluntary written consent to participate in the study.

Exclusion Criteria

  • 1) Renal dysfunction with an eGFR of less than 30 (excluding dialysis patients).
  • 2) The patient who has one of the following cardiac diseases
  • a) Heart failure of NYHA class 3 or higher.
  • b) Current symptomatic coronary artery disease or a history of myocardial infarction within 4 weeks prior to enrollment.
  • 3) Serious and active infection (CTCAE version 4.0 Grade 3 or higher)
  • 4) Pregnant women, lactating women, and women who may or will become pregnant (if pregnancy is suspected, a pregnancy test should be performed).
  • 5) Other risks that may jeopardize patient safety or make it difficult to comply with the study protocol.

Investigators

Sponsor
Kato Naoya

Similar Trials